Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olfr849 Inhibitors

Olfr849, a member of the olfactory receptor (OR) family, plays a crucial role in the detection and transduction of olfactory signals. As a G-protein coupled receptor (GPCR), it is involved in the intricate process of olfaction, where the binding of specific odorant molecules to the receptor triggers a series of cellular responses, ultimately leading to the perception of smell. The activation of Olfr849, like other olfactory receptors, involves the binding of odorant molecules, which prompts the associated G-protein to initiate intracellular signaling cascades, predominantly via the adenylate cyclase pathway leading to the generation of cAMP, or through phospholipase C (PLC) pathways resulting in the production of IP3 and diacylglycerol (DAG). This biochemical process is essential for converting chemical signals (odors) into electrical signals that are interpreted by the brain as distinct smells. Direct inhibitors of Olfr849 would typically be molecules that can competitively bind to the receptor, thereby blocking its interaction with natural odorants. However, identifying direct inhibitors for specific olfactory receptors like Olfr849 is a complex task due to the high specificity and diversity of these receptors. Therefore, exploring indirect inhibitors that can modulate the signaling pathways or cellular processes associated with the receptor's function becomes a viable approach. The indirect inhibition of Olfr849 involves targeting various components of the olfactory signal transduction pathway. For instance, compounds that inhibit the enzymes responsible for the synthesis or degradation of second messengers like cAMP and IP3 can indirectly affect the receptor's function. By altering the levels of these messengers, the cellular response to the receptor's activation can be modulated.

Another indirect inhibition strategy involves targeting the G-protein itself. Since G-proteins are pivotal in linking the receptor activation to downstream signaling cascades, modulating their activity can influence the receptor's function. Compounds that interfere with the G-protein subunits or their regulatory mechanisms can disrupt the signaling pathway, thus altering the receptor's response. Additionally, the receptor's internalization, desensitization, and recycling processes are integral to its functional regulation. Chemicals that influence these aspects can serve as indirect inhibitors by affecting the receptor's availability and responsiveness on the cell surface. Furthermore, the intracellular signaling pathways activated by the receptor, such as the MAPK, PI3K/Akt, and PKC pathways, present additional targets for indirect inhibition. Compounds that inhibit key enzymes or regulatory proteins within these pathways can attenuate the cellular responses initiated by the receptor's activation. This can be particularly relevant in the context of olfactory receptors as they depend on a cascade of intracellular events for signal transduction.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

Brefeldin A inhibits ADP-ribosylation factor, a GTPase essential for vesicle formation. This impacts the cellular trafficking of GPCRs like Olfr849, thus affecting their signaling and surface expression.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

Genistein, as a tyrosine kinase inhibitor, also modulates GPCR activity. It influences downstream signaling pathways like PI3K and MAPK, indirectly impacting Olfr849's signal transduction mechanisms.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002, a PI3K inhibitor, affects Akt signaling pathways. This modulation indirectly influences GPCR-mediated pathways, including those of Olfr849, altering receptor internalization and downstream responses.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

U0126 acts as a MEK inhibitor, disrupting the MAPK/ERK pathway. This inhibition indirectly affects GPCRs like Olfr849 by modifying their signaling processes and expression.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 specifically inhibits MEK in the MAPK pathway, resulting in changes to GPCR signaling. This indirectly impacts Olfr849's function by modulating its downstream signaling routes.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 inhibits p38 MAPK, affecting the MAPK signaling pathway. This alteration indirectly influences GPCR signaling, impacting the signaling and cellular response of Olfr849.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin, an mTOR inhibitor, indirectly affects GPCR signaling pathways by altering cellular metabolic states and response mechanisms, thus influencing Olfr849's activity.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin is a PI3K inhibitor disrupting PI3K-dependent pathways. This affects GPCR-mediated signaling, including Olfr849's, by impacting receptor trafficking and downstream signaling.

Gö 6976

136194-77-9sc-221684
500 µg
$227.00
8
(1)

Go6976, a protein kinase C inhibitor, affects PKC-mediated pathways, thereby indirectly altering GPCR signaling and impacting Olfr849's function and signaling efficiency.

NF449

627034-85-9sc-478179
sc-478179A
sc-478179B
10 mg
25 mg
100 mg
$203.00
$469.00
$1509.00
1
(0)

NF449, a Gsα subunit inhibitor, disrupts Gsα-mediated signaling, indirectly influencing GPCR activity and affecting Olfr849's cellular signaling processes.